BR0013179A - Compostos de oxoazaeterociclila substituìda - Google Patents

Compostos de oxoazaeterociclila substituìda

Info

Publication number
BR0013179A
BR0013179A BR0013179-2A BR0013179A BR0013179A BR 0013179 A BR0013179 A BR 0013179A BR 0013179 A BR0013179 A BR 0013179A BR 0013179 A BR0013179 A BR 0013179A
Authority
BR
Brazil
Prior art keywords
compounds
oxoazaeterocyclyl
factor
substituted
inhibiting
Prior art date
Application number
BR0013179-2A
Other languages
English (en)
Inventor
William R Ewing
Michael R Becker
Yong Mi Choi-Sledeski
Heinz W Pauls
Wei He
Stephen M Condon
Roderick S Davis
Barbara A Hanney
Alfred P Spada
Christopher J Burns
John Z Jiang
Aiwen Li
Michael R Myers
Wan F Lau
Gregory B Poli
Original Assignee
Aventis Pharm Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharm Prod Inc filed Critical Aventis Pharm Prod Inc
Publication of BR0013179A publication Critical patent/BR0013179A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Abstract

Patente de Invenção: "COMPOSTOS DE OXOAZAETEROCICLILA SUBSTITUìDA". Esta invenção é direcionada aos compostos de oxoazaeterociclila que inibem o Fator Xa, aos compostos de oxoazaeterociclila que inibem tanto o Fator Xa como o Fator IIa, às composições farmacêuticas que compreendem estes compostos, aos intermediários úteis para preparar estes compostos, a um método de diretamente inibir o Fator Xa e a um método de diretamente inibir de forma simultânea o Fator Xa e o Fator IIa.
BR0013179-2A 1999-07-28 2000-07-26 Compostos de oxoazaeterociclila substituìda BR0013179A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36319699A 1999-07-28 1999-07-28
PCT/IB2000/001156 WO2001007436A2 (en) 1999-07-28 2000-07-26 Substituted oxoazaheterocyclyl compounds

Publications (1)

Publication Number Publication Date
BR0013179A true BR0013179A (pt) 2002-04-02

Family

ID=23429232

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013179-2A BR0013179A (pt) 1999-07-28 2000-07-26 Compostos de oxoazaeterociclila substituìda

Country Status (25)

Country Link
EP (1) EP1208097B1 (pt)
JP (1) JP4829449B2 (pt)
KR (1) KR20020087041A (pt)
CN (1) CN1420882A (pt)
AT (1) ATE423113T1 (pt)
AU (1) AU773227B2 (pt)
BG (1) BG106340A (pt)
BR (1) BR0013179A (pt)
CA (1) CA2382755A1 (pt)
CR (1) CR6563A (pt)
CZ (1) CZ2002323A3 (pt)
DE (1) DE60041584D1 (pt)
EE (1) EE200200045A (pt)
HK (1) HK1054227A1 (pt)
HR (1) HRP20020076A2 (pt)
HU (1) HUP0203375A3 (pt)
IL (2) IL147495A0 (pt)
MX (1) MXPA02000888A (pt)
NO (1) NO20020214L (pt)
PL (1) PL354998A1 (pt)
RU (1) RU2002105011A (pt)
SK (1) SK1182002A3 (pt)
TR (1) TR200200225T2 (pt)
WO (1) WO2001007436A2 (pt)
ZA (1) ZA200200543B (pt)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005893B1 (ru) 2000-03-21 2005-06-30 Смитклайн Бичам Корпорейшн Ингибиторы протеаз
AU2002211280A1 (en) * 2000-09-29 2002-04-08 Cor Therapeutics, Inc. Piperazin-2-one amides as inhibitors of factor Xa
CZ303750B6 (cs) * 2001-02-02 2013-04-17 Bristol-Myers Squibb Company Prostredky obsahující substituované deriváty azaindoloxoacetylpiperazinu a jejich antivirová aktivita
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0114005D0 (en) 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
GB0114004D0 (en) 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
HUP0401886A2 (hu) 2001-07-02 2004-12-28 Astrazeneca Ab, Kemokin receptor aktivitás modulátorokként alkalmazható piperidinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
GB0120461D0 (en) 2001-08-22 2001-10-17 Astrazeneca Ab Novel compounds
AU2007229363B2 (en) * 2001-08-24 2009-06-04 University Of South Florida Piperazinone Compounds as Anti-Tumor and Anti-Cancer Agents and the Methods of Treatment
DE60234354D1 (de) * 2001-08-24 2009-12-24 Univ Yale Piperazinon-verbindungen als antitumorale und krebsbekämpfende mittel
GB0122503D0 (en) 2001-09-18 2001-11-07 Astrazeneca Ab Chemical compounds
EP1314733A1 (en) 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides as factor Xa inhibitors
WO2003075853A2 (en) 2002-03-08 2003-09-18 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
SE0200844D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0200843D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
AU2003231359B2 (en) 2002-04-16 2009-04-30 Teijin Limited Piperidine derivatives having CCR3 antagonism
CA2483504A1 (en) 2002-04-25 2003-11-06 Teijin Limited 4,4-(disubstituted)piperidine derivatives with ccr3 antagonism
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
AU2003272972A1 (en) * 2002-10-11 2004-05-04 Kowa Co., Ltd. Method of treatment for cancer
US7358268B2 (en) 2002-12-04 2008-04-15 Sanofi-Aventis Deutschland Gmbh Imidazole derivatives as factor Xa inhibitors
ATE443699T1 (de) * 2002-12-06 2009-10-15 Purdue Research Foundation Pyridine zur behandlung von verletztemsäugetiernervengewebe
US8729107B2 (en) 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
US7429581B2 (en) 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
US8044206B2 (en) 2003-03-07 2011-10-25 Astellas Pharma Inc. Nitrogen—containing heterocyclic derivatives having 2,6-disubstituted styryl
SE0300957D0 (sv) 2003-04-01 2003-04-01 Astrazeneca Ab Chemical compounds
US7741341B2 (en) 2003-05-19 2010-06-22 Sanofi-Aventis Deutschland Gmbh Benzimidazole-derivatives as factor Xa inhibitors
US7317027B2 (en) 2003-05-19 2008-01-08 Sanofi-Aventis Deutschland Gmbh Azaindole-derivatives as factor Xa inhibitors
US7223780B2 (en) 2003-05-19 2007-05-29 Sanofi-Aventis Deutschland Gmbh Triazole-derivatives as blood clotting enzyme factor Xa inhibitors
EP1479675A1 (en) 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Indazole-derivatives as factor Xa inhibitors
GB0315111D0 (en) 2003-06-27 2003-07-30 Cancer Rec Tech Ltd Substituted 5-membered ring compounds and their use
RS20060035A (en) 2003-07-22 2008-08-07 Arena Pharmaceuticals Inc., Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
US7393865B2 (en) 2004-06-17 2008-07-01 Neurocrine Biosciences, Inc. Sleep inducing compounds and methods relating thereto
GB0420831D0 (en) 2004-09-17 2004-10-20 Glaxo Group Ltd Novel compounds
RU2408580C2 (ru) 2005-02-17 2011-01-10 Астеллас Фарма Инк. Пиридильное неароматическое азотсодержащее гетероцикло-1-карбоксилатное производное
WO2007008144A1 (en) * 2005-07-08 2007-01-18 Astrazeneca Ab Heterocyclic sulfonamide derivatives as inhibitors of factor xa
US20080200431A1 (en) * 2005-07-08 2008-08-21 Astrazeneca Ab Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa
CA2615650A1 (en) 2005-07-21 2007-01-25 Astrazeneca Ab Novel piperidine derivatives
WO2007029629A1 (ja) * 2005-09-06 2007-03-15 Shionogi & Co., Ltd. Ｐｇｄ２受容体アンタゴニスト活性を有するインドールカルボン酸誘導体
EP2270014A1 (en) 2005-09-22 2011-01-05 Incyte Corporation Azepine inhibitors of janus kinases
RU2405770C2 (ru) 2005-09-27 2010-12-10 Сионоги Энд Ко., Лтд. Производное сульфонамида, обладающее антагонистической активностью в отношении рецептора pgd2
CN102690221B (zh) 2005-12-23 2014-12-03 西兰岛药物有限公司 改性的拟赖氨酸化合物
WO2007099828A1 (ja) 2006-02-23 2007-09-07 Shionogi & Co., Ltd. 環式基で置換された含窒素複素環誘導体
WO2007118130A2 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Antibacterial agents
US8017612B2 (en) 2006-04-18 2011-09-13 Japan Tobacco Inc. Piperazine compound and use thereof as a HCV polymerase inhibitor
JP2009541214A (ja) * 2006-05-26 2009-11-26 ユニバーシティ・オブ・ルーイビル・リサーチ・ファウンデーション・インコーポレーテッド マクロファージ遊走阻止因子アンタゴニスト及びそれを用いた方法
EP1882688A1 (en) * 2006-07-25 2008-01-30 EPFL Ecole Polytechnique Fédérale de Lausanne Labelling of fusion proteins with synthetic probes
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
DK2468724T3 (en) 2006-12-21 2016-02-22 Zealand Pharma As Synthesis of pyrrolidine compounds
NZ579635A (en) * 2007-03-20 2011-07-29 Curis Inc Fused amino pyridine as hsp90 inhibitors
WO2009023253A2 (en) 2007-08-15 2009-02-19 Arena Pharmaceuticals Inc. IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
TW200944526A (en) 2008-04-22 2009-11-01 Vitae Pharmaceuticals Inc Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
CN102264354B (zh) 2008-10-28 2015-03-25 艾尼纳制药公司 用于治疗5-ht2a5-羟色胺受体相关障碍的5-ht2a5-羟色胺受体调节剂组合物
EP2480235A4 (en) 2009-09-24 2013-05-08 Univ Louisville Res Found NEW IODO-PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ILLNESSES AND SUFFERING IN CONNECTION WITH THE MACROPHAGE MIGRATION-INHIBITING FACTOR
WO2011146824A1 (en) 2010-05-20 2011-11-24 University Of Louisville Research Foundation, Inc. Methods and compositions for modulating ocular damage
KR101251282B1 (ko) 2010-10-18 2013-04-10 서울대학교산학협력단 프로스타글란딘 합성을 억제하는 설폰아미드 유도체 및 이를 포함하는 약학적 조성물
CN103261205B (zh) * 2010-11-12 2015-08-19 姚雪彪 动点马达蛋白cenp-e小分子抑制剂syntelin及其应用
WO2012071369A2 (en) 2010-11-24 2012-05-31 The Trustees Of Columbia University In The City Of New York A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
PL395470A1 (pl) 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Sulfonamidowe pochodne amin alicyklicznych do leczenia chorób osrodkowego ukladu nerwowego
WO2013166037A1 (en) 2012-05-01 2013-11-07 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of eye disorders
US10273243B2 (en) 2013-03-14 2019-04-30 The Trustees Of Columbia University In The City Of New York 4-phenylpiperidines, their preparation and use
WO2014151959A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
ES2700541T3 (es) 2013-03-14 2019-02-18 Univ Columbia Octahidrociclopentapirroles, su preparación y uso
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
US9944644B2 (en) 2013-03-14 2018-04-17 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles their preparation and use
CN106794364B (zh) 2014-04-30 2019-12-24 哥伦比亚大学董事会 取代的4-苯基哌啶及其制备和用途
PT3174858T (pt) 2014-07-31 2019-07-23 Basf Se Processo para preparar pirazoles
CN104592227B (zh) * 2015-02-14 2016-06-01 佛山市赛维斯医药科技有限公司 一类含酰胺和卤代苯结构的FXa抑制剂、制备方法及其用途
CN104610260B (zh) * 2015-02-14 2016-03-30 佛山市赛维斯医药科技有限公司 一类含酰胺和氮杂环结构的FXa抑制剂、制备方法及其用途
CN104557930B (zh) * 2015-02-14 2016-06-01 佛山市赛维斯医药科技有限公司 一种含二环酰胺结构凝血因子Xa抑制剂及其用途
CN104650081B (zh) * 2015-02-14 2016-06-01 佛山市赛维斯医药科技有限公司 凝血因子Xa抑制剂、制备方法及其用途
CN104672236B (zh) * 2015-02-14 2016-03-30 佛山市赛维斯医药科技有限公司 一类含双酰胺基和卤代苯结构的FXa抑制剂及其用途
CN104557927B (zh) * 2015-02-14 2016-06-01 佛山市赛维斯医药科技有限公司 一种含二环酰胺结构的凝血因子Xa抑制剂及其用途
CN104557929B (zh) * 2015-02-14 2016-06-01 佛山市赛维斯医药科技有限公司 一类含二环酰胺结构的凝血因子Xa抑制剂及其用途
CN104610257B (zh) * 2015-02-14 2016-06-01 佛山市赛维斯医药科技有限公司 一类含酰胺结构的FXa抑制剂、制备方法及其用途
CN104610258B (zh) * 2015-02-14 2016-03-30 佛山市赛维斯医药科技有限公司 一类含酰胺和甲氧苯结构的FXa抑制剂、制备方法及其用途
CN104557928B (zh) * 2015-02-14 2016-08-24 佛山市赛维斯医药科技有限公司 一种含二环酰胺结构凝血因子Xa抑制剂、其制备方法及其用途
CN104672235B (zh) * 2015-02-14 2016-02-17 佛山市赛维斯医药科技有限公司 一类含双酰胺基和烷氧苯基结构的FXa抑制剂及其用途
CN104610259B (zh) * 2015-02-14 2016-06-01 佛山市赛维斯医药科技有限公司 含酰胺和氮杂环结构的FXa抑制剂、制备方法及其用途
CN104650082B (zh) * 2015-02-14 2016-06-01 佛山市赛维斯医药科技有限公司 一类凝血因子Xa抑制剂、制备方法及其用途
ES2882543T3 (es) 2015-05-11 2021-12-02 Basf Se Proceso para la preparación de 4-amino-piridazinas
JP2018516992A (ja) 2015-06-12 2018-06-28 アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
EA201890152A1 (ru) 2015-06-26 2018-08-31 Такеда Фармасьютикал Компани Лимитед Производные 2,3-дигидро-4h-1,3-бензоксазин-4-онов в качестве модуляторов холинергического мускаринового m1 рецептора
BR112018000728A2 (pt) 2015-07-15 2018-09-04 Axovant Sciences Gmbh resumo método para a profilaxia e/ou tratamento de alucinações visuais em um sujeito com necessidade do mesmo
EP3366679B1 (en) * 2015-10-20 2021-03-24 Takeda Pharmaceutical Company Limited Heterocyclic compound
WO2018082964A1 (en) 2016-11-04 2018-05-11 Basf Se Process for the production of pyridazinyl-amides in a one-pot synthesis
US11560372B2 (en) 2017-04-18 2023-01-24 Takeda Pharmaceutical Company Limited Heterocyclic compounds useful as modulators of acetylcholine receptors
EP3618847B1 (en) 2017-05-05 2021-04-07 Zealand Pharma A/S Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease
CN110054619A (zh) * 2018-01-18 2019-07-26 西北农林科技大学 新型二酮哌嗪类组蛋白去乙酰化酶抑制剂
BR112020020663A2 (pt) 2018-04-10 2021-01-12 Bayer Aktiengesellschaft Derivados de oxadiazolina
CN109991355B (zh) * 2019-04-12 2021-05-11 中国烟草总公司郑州烟草研究院 一种鉴定动物体内nab代谢产物的方法和评价nab在动物体内暴露风险的方法
WO2022228387A1 (en) * 2021-04-26 2022-11-03 Fochon Biosciences, Ltd. Compounds as parp inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK102495A3 (en) * 1993-02-22 1997-01-08 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical agents containing them
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5612353A (en) * 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
UA56197C2 (uk) * 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
NZ500354A (en) * 1997-04-14 2001-11-30 Cor Therapeutics Inc Cyclic diaza compounds as selective factor Xa inhibitors for treating thrombotic related disorders
CA2318351A1 (en) * 1997-12-26 1999-07-08 Hidemitsu Nishida Aromatic compounds having cyclic amino or salts thereof
EA200000768A1 (ru) * 1998-01-27 2001-06-25 Эвентис Фармасьютикалз Продактс Инк. ЗАМЕЩЕННЫЕ ОКСОАЗАГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ ФАКТОРА Ха
WO1999040075A1 (fr) * 1998-02-05 1999-08-12 Takeda Chemical Industries, Ltd. Derives de sulfamide, leur procede de production et leur utilisation
JP2000204081A (ja) * 1998-02-05 2000-07-25 Takeda Chem Ind Ltd スルホンアミド誘導体、その製造法及び用途
JP2003529531A (ja) * 1998-11-25 2003-10-07 アヴェンティス ファーマシューティカルズ インコーポレイテッド 置換オキソアザへテロシクリルＸａ因子阻害剤

Also Published As

Publication number Publication date
NO20020214L (no) 2002-04-02
EE200200045A (et) 2003-06-16
EP1208097A2 (en) 2002-05-29
CA2382755A1 (en) 2001-02-01
BG106340A (en) 2002-10-31
CZ2002323A3 (cs) 2002-05-15
DE60041584D1 (de) 2009-04-02
WO2001007436A2 (en) 2001-02-01
CR6563A (es) 2008-11-25
HRP20020076A2 (en) 2003-12-31
JP2003508353A (ja) 2003-03-04
EP1208097B1 (en) 2009-02-18
ZA200200543B (en) 2003-08-27
ATE423113T1 (de) 2009-03-15
AU773227B2 (en) 2004-05-20
TR200200225T2 (tr) 2002-06-21
NO20020214D0 (no) 2002-01-15
IL147495A (en) 2007-07-24
AU6462800A (en) 2001-02-13
RU2002105011A (ru) 2004-01-20
IL147495A0 (en) 2002-08-14
HUP0203375A3 (en) 2005-03-29
HK1054227A1 (zh) 2003-11-21
JP4829449B2 (ja) 2011-12-07
SK1182002A3 (en) 2002-11-06
WO2001007436A3 (en) 2001-08-23
CN1420882A (zh) 2003-05-28
PL354998A1 (en) 2004-03-22
MXPA02000888A (es) 2002-07-30
HUP0203375A2 (hu) 2002-12-28
KR20020087041A (ko) 2002-11-21

Similar Documents

Publication Publication Date Title
BR0013179A (pt) Compostos de oxoazaeterociclila substituìda
BR9907300A (pt) Inibidores do fator xa oxoaza-heterociclila substituìdos
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
ATE297203T1 (de) Antithrombotische mitteln
PA8543301A1 (es) Derivados de dihidro-benzo (b) (1,4) diazepin-2 -ona como antagonistas ii mglur2
ECSP056130A (es) Compuestos farmacéuticos novedosos
UY28625A1 (es) Nuevos compuestos farmacéuticos
DE69919212D1 (de) Aromatische amiden
BR0115452A (pt) Compostos tendo atividade fungicida e processos para fabricação e uso dos mesmos
BRPI0414130A (pt) compostos de fenilamida ou piridilamida como antagonistas de prostaglandina e2
CL2004000969A1 (es) Compuestos derivados de alquilarilo; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento y/o profilaxis de la obesidad y trastornos relacionados.
CU23148A3 (es) Compuestos azapoliciclicos condensados con arilo
DOP2005000071A (es) "compuestos de metil-aril o heteroaril-amida sustituida"
UY28482A1 (es) Nuevos compuestos
ECSP034830A (es) Derivados sustituidos de la ciclohexano-1,4- diamina
BR0002515A (pt) Derivados de 4-arilpiperidina para o tratamento do prurido
BR0311494A (pt) Novos indóis substituìdos
UY29004A1 (es) Compuestos derivados sustituídos de ácidos, glicina y alanina; procedimiento para su preparación y uso.
BR0002518A (pt) Derivados de 4-arilpiperidina para o tratamento de prurido
NO20032208D0 (no) Benzodiazepinderivater som GABA A reseptormodulatorer
BR0115291A (pt) Derivados de 2-fenilaminoimidazolina fenil cetona substituìdos como antagonistas de ip
BR0204678A (pt) Inibidor de nf-kb contendo derivado de ácido benzóico substituìdo como ingrediente ativo
BR0015384A (pt) Processo para a preparação de um composto, e, composto
UY27786A1 (es) Derivados de isoquinolina.
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.